2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Pleural Effusion, Malignant in 1 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
Pleural Effusion, Malignant: Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Starr, AN | 1 |
| Vexler, A | 1 |
| Marmor, S | 1 |
| Konik, D | 1 |
| Ashkenasi-Voghera, M | 1 |
| Lev-Ari, S | 1 |
| Greif, Y | 1 |
| Ben-Yosef, R | 1 |
1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Establishment and characterization of a pancreatic carcinoma cell line derived from malignant pleural effusion.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinogenicity Tests; Cell Cycle; Cell Line, Tumor; | 2005 |